Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Isogenica

Isogenica

Isogenica is a drug discovery platform-licensing company focusing on the design and build of diverse, fully synthetic, antibody libraries for use in biopharmaceutical discovery. Partners can access an advanced camelid single-domain antibody library (llamdA™) and state-of-the-art, fully synthetic and highly diverse human Fab antibody libraries (Alexandria™). The company uses its proprietary Colibra™ library technology to ensure that the libraries very accurately reflect its advanced designs. Libraries can be screened in various formats, including phage and CIS Display, a proprietary in vitro display technology which maintains the high diversity of the llamdA™ libraries through the discovery process. CIS Display is also available as a stand-alone polypeptide display technology.

Last updated on

About Isogenica

Founded

2001

Estimated Revenue

$1M-$10M

Employees

11-50

Funding / Mkt. Cap

$9M

Category

Sector

Commercial Physical and Biological Research

Industry Group

Research, Development, and Testing Services

Industry

Biotechnology

Location

City

Little Chesterford

State

Essex

Country

United Kingdom
Isogenica

Isogenica

Find your buyer within Isogenica

Tech Stack (40)

search